0
0
If you or a loved one have been diagnosed with macular degeneration or another eye condition after taking the popular retina drug Elmiron, you may be wondering if you have any legal recourse. Here’s an update on the latest developments in the Elmiron eye damage lawsuit.
Elmiron is a medication used to treat a condition called interstitial cystitis, which is a chronic inflammation of the bladder. Elmiron has been on the market since 1996 and is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. In recent years, however, mounting evidence has emerged linking Elmiron to a serious eye condition known as macular degeneration.
Macular degeneration is a progressive condition that leads to vision loss and blindness. Early symptoms of macular degeneration include difficulty adjusting to low light, trouble reading or analyzing fine details, and decreased central vision. There is no cure for macular degeneration, and once vision is lost, it cannot be regained. As such, macular degeneration is a life-altering diagnosis for those who develop the condition.
Interestingly, while Elmiron has been on the market for more than two decades, reports of macular degeneration linked to the drug only began surfacing in recent years. One reason for this may be that it can take many years for the condition to develop after exposure to the drug. Another possibility is that as awareness of the link between Elmiron and macular degeneration has increased, more people have come forward with their stories.
Conclusion:
If you or someone you love has been diagnosed with macular degeneration or another eye condition after taking Elmiron, you may be wondering if you have any legal recourse. While the FDA has not yet issued a recall for Elmiron, several lawsuits have been filed against Janssen Pharmaceuticals alleging that the company failed to warn consumers about the risk of vision loss associated with the drug. If you believe you may have a case, contact an experienced attorney today for more information.
